229 related articles for article (PubMed ID: 37308680)
1. Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse.
Clauss NJ; Mayer FP; Owens WA; Vitela M; Clarke KM; Bowman MA; Horton RE; Gründemann D; Schmid D; Holy M; Gould GG; Koek W; Sitte HH; Daws LC
Mol Psychiatry; 2023 Jul; 28(7):2934-2945. PubMed ID: 37308680
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
[TBL] [Abstract][Full Text] [Related]
3. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
[TBL] [Abstract][Full Text] [Related]
5. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
[TBL] [Abstract][Full Text] [Related]
6. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
7. Organic Cation Transporters in Psychiatric Disorders.
Daws LC
Handb Exp Pharmacol; 2021; 266():215-239. PubMed ID: 34282486
[TBL] [Abstract][Full Text] [Related]
8. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
11. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter inhibition and 5-HT
Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
[TBL] [Abstract][Full Text] [Related]
14. SAR studies of piperidine-based analogues of cocaine. 4. Effect of N-modification and ester replacement.
Petukhov PA; Zhang J; Kozikowski AP; Wang CZ; Ye YP; Johnson KM; Tella SR
J Med Chem; 2002 Jul; 45(15):3161-70. PubMed ID: 12109901
[TBL] [Abstract][Full Text] [Related]
15. Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.
Jones JD; Hall FS; Uhl GR; Riley AL
Pharmacol Biochem Behav; 2010 Feb; 94(4):580-7. PubMed ID: 19969013
[TBL] [Abstract][Full Text] [Related]
16. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.
Fraser-Spears R; Krause-Heuer AM; Basiouny M; Mayer FP; Manishimwe R; Wyatt NA; Dobrowolski JC; Roberts MP; Greguric I; Kumar N; Koek W; Sitte HH; Callaghan PD; Fraser BH; Daws LC
Eur J Pharmacol; 2019 Jan; 842():351-364. PubMed ID: 30473490
[TBL] [Abstract][Full Text] [Related]
18. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
19. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
20. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
